Ofer Daphna News Today

EyeYon Medical Receives CE Mark for its EndoArt® Implant to Treat Chronic Corneal Edema Font : A-A+ EndoArt® previously received Innovative Device Status by the Chinese NMPA, and Breakthrough Device Designation from the US Food and Drug Administration TEL AVIV, Israel, June 8, 2021 /PRNewswire/ -- EyeYon Medical, an Israeli start-up company developing a variety of ophthalmic products for vision-threatening conditions, announced today that it has received CE Mark for its EndoArt®, after cl...

Israeli cornea treatment co EyeYon raises $25m The Israeli company will use the capital to expand clinical trials to treat corneal endema. Israeli medical device company EyeYon Medical EyeYon Medical today announced the completion of a $25 million Series C financing round, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund, together with Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing investors Triventures, Rimonci, P...

EyeYon Medical Raises $25 million in Series C to Transform Corneal Care USA - English News provided by Share this article Share this article TEL AVIV, Israel, March 15, 2021 /PRNewswire/ -- EyeYon Medical announced today the completion of a $25 million in a Series C funding, led by a global strategic leader in the ophthalmic industry and CR-CP Life Science Fund. Other participants in the round include Global Health Sciences (GHS) Fund (Quark Venture LP and GF Securities), BPC and existing inve...